避孕药市场规模、份额、成长分析、按产品、分销管道、按地区 - 行业预测，2024-2031

2022年避孕药具市场规模为282.2亿美元，从2023年的303.1亿美元成长到2031年的536.5亿美元，复合年增长率预计为7.40%。

由于计划生育意识不断提高、性行为感染感染 (STI) 发病率上升以及对有效避孕解决方案的需求不断增长，全球避孕药市场正在强劲增长。包括长效可逆避孕药（LARC）和多样化可用选择在内的关键进步正在进一步刺激市场扩张。政府促进生殖健康的措施正在改善市场条件。然而，社会耻辱、文化障碍和某些领域的准入有限等挑战可能会阻碍成长。儘管存在这些障碍，但由于人们对妇女健康的认识不断提高以及人们普遍接受避孕作为赋权工具，全球避孕市场预计将继续增长。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步
• 监管环境
• 案例研究
• 客户和购买标准分析
• 贸易分析
• 原料分析

避孕药具市场规模：依产品分类

• 市场概况
• 避孕药
  • 避孕药
  • 修补
  • 注射
• 避孕器
  • 保险套
  • 男用保险套
  • 女性用保险套
  • 皮下植入
  • 子宫内避孕器 (IUDS)
  • 铜子宫内避孕器
  • 荷尔蒙子宫内避孕器
  • 避孕环
  • 隔膜

避孕药具市场规模：依通路分类

• 市场概况
• 医疗机构
• 药局
• 其他的

避孕药具市场规模：依地区划分

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Bayer AG
• Pfizer Inc.
• Merck & Co., Inc.
• Teva Pharmaceutical Industries Ltd.
• Organon & Co.
• Agile Therapeutics
• Mayer Laboratories, Inc.
• CooperSurgical, Inc.
• Afaxys, Inc.
• Mylan NV（Viatris）
• DKT International
• Medisafe Distribution Inc.
• Veru Inc.
• Cipla Ltd.
• Lupin Pharmaceuticals
• Mithra Pharmaceuticals
• Pregna International Limited
• Fuji Latex Co., Ltd.
• Karex Berhad
• Cupid Limited

结论和建议

Contraceptives Market size was valued at USD 28.22 billion in 2022 and is poised to grow from USD 30.31 billion in 2023 to USD 53.65 billion by 2031, growing at a CAGR of 7.40% in the forecast period (2024-2031).

The global contraceptives market is experiencing robust growth, propelled by heightened awareness of family planning, a rise in sexually transmitted infections (STIs), and an increased demand for effective contraceptive solutions. Key advancements, including long-acting reversible contraceptives (LARCs) and a diverse range of available options, are further stimulating market expansion. Government initiatives promoting reproductive health enhance market conditions. However, challenges such as social stigma, cultural barriers, and limited access in certain regions can hinder growth. Despite these obstacles, the growing focus on women's health and the broadening acceptance of contraception as a tool for empowerment are poised to foster continued growth in the global contraceptives market in the years ahead.

Top-down and bottom-up approaches were used to estimate and validate the size of the Contraceptives market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Contraceptives Market Segmental Analysis

Global Contraceptives Market is segmented by product, distribution channel and region. Based on product, the market is segmented into contraceptive drugs and contraceptive devices. Based on distribution channel, the market is segmented into healthcare facilities, pharmacies and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Contraceptives Market

A major catalyst for the global contraceptives market is the rising awareness and acceptance surrounding family planning and reproductive health. As communities become more informed about the critical role of contraception in managing population growth and improving women's health, the demand for contraceptive options has surged considerably. This uptick is further bolstered by government initiatives and programs that advocate for family planning, as well as the dedicated efforts of various organizations working to enhance public understanding of contraceptive methods. Consequently, the convergence of education, policy support, and advocacy has fueled substantial growth within the contraceptives market.

Restraints in the Contraceptives Market

The global contraceptives market faces significant constraints primarily due to cultural and religious barriers that impede the acceptance and utilization of contraceptives in various regions. In many communities, prevailing cultural and religious norms discourage or outright prohibit contraceptive use, resulting in diminished adoption rates. Additionally, insufficient accessibility, particularly in rural and remote areas, compounds these challenges. Factors such as limited availability, high costs, and inadequate distribution networks further restrict access to contraceptives, especially in developing nations. Addressing these cultural and logistical obstacles is essential for fostering market expansion and achieving universal access to effective contraception methods.

Market Trends of the Contraceptives Market

The global contraceptives market is witnessing a significant trend towards the increasing adoption of long-acting reversible contraceptives (LARCs), such as intrauterine devices (IUDs) and contraceptive implants. These options are favored for their high efficacy and convenience, as they require minimal maintenance compared to traditional methods. As women seek reliable, hassle-free solutions, LARCs are becoming increasingly popular, reflecting a broader shift towards effective and sustainable contraceptive solutions. Technological advancements have further enhanced the appeal of LARCs, leading to the development of innovative, user-friendly products that cater to evolving consumer needs. This shift underscores a growing preference for modern contraceptive methods in the global market landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Customer & Buying Criteria Analysis
• Trade Analysis
• Raw Material Analysis

Global Contraceptives Market Size by Product & CAGR (2024-2031)

• Market Overview
• Contraceptive Drugs
  • Contraceptive Pills
  • Patch
  • Injectables
• Contraceptive Devices
  • Condom
  • Male Condom
  • Female Condom
  • Subdermal Implants
  • Intrauterine Devices (IUDS)
  • Copper IUDS
  • Hormonal IUDS
  • Vaginal Ring
  • Diaphragm

Global Contraceptives Market Size by Distribution Channel & CAGR (2024-2031)

• Market Overview
• Healthcare Facilities
• Pharmacies
• Others

Global Contraceptives Market Size & CAGR (2024-2031)

• North America (Product, Distribution Channel)
  • USA
  • Canada
• Europe (Product, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organon & Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agile Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayer Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Afaxys, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (Viatris)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DKT International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medisafe Distribution Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veru Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mithra Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pregna International Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fuji Latex Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Karex Berhad
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cupid Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations